Rationale and design of the pilot randomized study of nesiritide versus dobutamine in heart failure (PRESERVD-HF).
Gheorghiade
Mihai
M
Division of Cardiology, Northwestern University, Feinberg School of Medicine, Chicago, Ill 60611, USA. m-gheorghiade@northwestern.edu
Gattis
Wendy A
WA
Adams
Kirkwood F
KF
Jaffe
Alan S
AS
O'Connor
Christopher M
CM
D002316:Cardiotonic Agents / Q000627:therapeutic use*; D018450:Disease Progression; D004280:Dobutamine / Q000627:therapeutic use*; D004311:Double-Blind Method; D023381:Endpoint Determination; D006333:Heart Failure / Q000097:blood / Q000188:drug therapy*; D006760:Hospitalization; D006801:Humans; D015337:Multicenter Studies as Topic / Q000379:methods*; D045283:Natriuretic Agents / Q000627:therapeutic use*; D020097:Natriuretic Peptide, Brain; D018579:Patient Selection; D010865:Pilot Projects; D016032:Randomized Controlled Trials as Topic / Q000379:methods*; D019210:Troponin I / Q000097:blood; D020107:Troponin T / Q000097:blood
D002316:Cardiotonic Agents; D045283:Natriuretic Agents; D019210:Troponin I; D020107:Troponin T; D020097:Natriuretic Peptide, Brain; D004280:Dobutamine